ASML Monopoly Faces US-Backed Rival, But Shares Hit New High
Startup led by former Intel CEO Pat Gelsinger secures initial CHIPS Act backing, yet investors focus on near-term AI demand, pushing stock higher.
A significant, state-backed challenge to ASML Holding N.V.’s monopoly on the world’s most advanced chipmaking technology emerged on Tuesday, yet the company’s shares shrugged off the long-term threat, climbing more than 2.6% to a new 52-week high in afternoon trading.
The U.S. Department of Commerce announced a non-binding letter of intent to provide up to $150 million in CHIPS and Science Act funding to xLight, a startup aiming to develop a next-generation alternative to ASML’s critical extreme ultraviolet (EUV) lithography machines. The venture is spearheaded by Pat Gelsinger, the former chief executive of Intel, who serves as xLight's executive chairman, lending immediate credibility to the ambitious project.
This funding marks the first major U.S. investment aimed directly at creating a domestic competitor in a field exclusively dominated by the Dutch technology giant. According to a press release from the National Institute of Standards and Technology (NIST), the investment from the CHIPS Research and Development Office is a strategic move to foster breakthrough lithography technology and reduce reliance on a single foreign supplier for a critical chokepoint in the semiconductor supply chain.
xLight is developing a system based on free-electron lasers (FEL), a different approach to generating the high-energy light required for EUV. The company claims its technology could eventually deliver four times the power of current EUV sources and potentially slash per-wafer costs by 50%. While the company is in its early stages, it has set a target of producing a feature-complete prototype by 2028.
For decades, ASML has been the sole supplier of EUV systems, the multi-million dollar machines essential for manufacturing advanced processors and memory chips for clients like TSMC, Samsung, and Intel. This technological supremacy has propelled ASML to a market capitalization of over $410 billion and cemented its role as one of the most indispensable companies in the global economy.
Despite the gravity of a U.S.-backed competitor emerging, investors on Tuesday appeared more focused on ASML’s overwhelmingly positive near-term outlook, which is being supercharged by the artificial intelligence boom. The market’s bullish sentiment was bolstered by recent analyst commentary, with JPMorgan Chase & Co. raising its price target on ASML to $1,275 on December 1, citing the company's pivotal role in the AI-driven semiconductor expansion. Morgan Stanley also recently reiterated an “Overweight” rating on the stock.
The market seems to be weighing ASML's packed order book for the coming years against a competitive threat that is still in its infancy. With a prototype at least four years away, the immediate financial impact on ASML is negligible, allowing investors to concentrate on the powerful demand for AI infrastructure that is driving profits today.
"The road to developing a viable alternative to ASML is incredibly long and expensive," one semiconductor analyst noted. "ASML has a multi-decade head start in technology, manufacturing, and deep integration with the world's top fabs. Investors are betting on the fortress ASML has already built."
Still, the xLight initiative represents a fundamental shift. It is the most credible effort yet to create an alternative in the EUV space, backed by significant government funding and the expertise of one of the industry's most respected veterans. This signals a clear U.S. strategy to de-risk its supply chain and onshore critical technologies, a theme that has gained bipartisan support.
While ASML’s dominance is secure for the foreseeable future, the creation of xLight plants a flag for long-term competition. For now, the market is content to celebrate the ongoing AI-fueled rally, but a new chapter in the high-stakes world of semiconductor technology has undeniably begun.